- Vysis FISH
- Abbott REAL-TIME PCR
- Ordering Information
For more information, contact Abbott.
ContactThe Vysis BIRC3/MALT1 DF FISH Probe Kit is intended to detect the t(11;18) (q21;q21) reciprocal translocation involving the BIRC3 (also know as API2) and MALT1 gene regions using the fluorescence in situ hybridization (FISH) technique.
The SpectrumOrange probe spans approximately 670 kb (chr18:54220804-54891192; March 2006 assembly) and covers the MALT1 gene region. The approximately 932 kb (chr11:101247706-102179265; March 2006 assembly) SpectrumGreen probe spans the BIRC3 gene region..
In a normal cell that lacks the t(11;18)(q21;q21) translocation, a two orange, two green signal pattern will be observed reflecting the two intact copies of MALT1 and BIRC3, respectively.
In an abnormal cell containing the t(11;18)(q21;q21) translocation, a one orange (MALT1), one green (BIRC3), and two fusion (BIRC3/MALT1 and MALT1/ BIRC3) signal pattern will be observed. Some samples containing the t(11;18) may display signal patterns differently than the one orange, one green, and two fusions.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.